Recombinant multi-species Albumin/ALB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Albumin/ALB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the most abundant protein in human blood. This protein functions in the regulation of blood plasma colloid osmotic pressure and acts as a carrier protein for a wide range of endogenous molecules including hormones, fatty acids, and metabolites, as well as exogenous drugs. Additionally, this protein exhibits an esterase-like activity with broad substrate specificity. The encoded preproprotein is proteolytically processed to generate the mature protein. A peptide derived from this protein, EPI-X4, is an endogenous inhibitor of the CXCR4 chemokine receptor. [provided by RefSeq, Jul 2016]
The Alternative Names of target: ALB,Alb,Alb-1,Alb1,Albumin,Albza,BCL002,CSA,FDAHT,HSA,PRO0883,PRO0903,PRO1341
Go
to Albumin/ALB products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T63068-Ag-1/ GM-Tg-hg-T63068-Ag-2 | Human Albumin/ALB protein | Human |
| GM-Tg-rg-T63068-Ag-1/ GM-Tg-rg-T63068-Ag-2 | Rat Albumin/ALB protein | Rat |
| GM-Tg-mg-T63068-Ag-1/ GM-Tg-mg-T63068-Ag-2 | Mouse Albumin/ALB protein | Mouse |
| GM-Tg-cynog-T63068-Ag-1/ GM-Tg-cynog-T63068-Ag-2 | Cynomolgus/Rhesus macaque Albumin/ALB protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T63068-Ag-1/ GM-Tg-felg-T63068-Ag-2 | Feline Albumin/ALB protein | Feline |
| GM-Tg-cang-T63068-Ag-1/ GM-Tg-cang-T63068-Ag-2 | Canine Albumin/ALB protein | Canine |
| GM-Tg-bovg-T63068-Ag-1/ GM-Tg-bovg-T63068-Ag-2 | Bovine Albumin/ALB protein | Bovine |
| GM-Tg-equg-T63068-Ag-1/ GM-Tg-equg-T63068-Ag-2 | Equine Albumin/ALB protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T63068-Ag-1/ GM-Tg-hg-T63068-Ag-2;
GM-Tg-rg-T63068-Ag-1/ GM-Tg-rg-T63068-Ag-2;
GM-Tg-mg-T63068-Ag-1/ GM-Tg-mg-T63068-Ag-2; GM-Tg-cynog-T63068-Ag-1/ GM-Tg-cynog-T63068-Ag-2; GM-Tg-felg-T63068-Ag-1/ GM-Tg-felg-T63068-Ag-2; GM-Tg-cang-T63068-Ag-1/ GM-Tg-cang-T63068-Ag-2; GM-Tg-bovg-T63068-Ag-1/ GM-Tg-bovg-T63068-Ag-2; GM-Tg-equg-T63068-Ag-1/ GM-Tg-equg-T63068-Ag-2 |
| Products Name | Albumin/ALB protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Albumin/ALB |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Albumin/ALB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.